Form 4 Tracker
Robert Iannone

Director; EVP, Global Head of R&D & CMO · 6 filings · Latest: Jul 9, 2026

Autolus Therapeutics plc
Jazz Pharmaceuticals plc
PLIANT THERAPEUTICS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
JAZZ
ROBERT IANNONENov 17, 2025
Proposed Sale
$168.267,159$1.2M
JAZZ
Iannone RobertMar 10, 2025
Proposed Sale
$145.001,767$256.2K
JAZZ
ROBERT IANNONEMar 7, 2025
Proposed Sale
$138.735,466$758.3K
JAZZ
Iannone RobertMar 7, 2025
Proposed Sale
$142.264,017$571.5K